(RTTNews) - SK bioscience announced positive results from its Phase II clinical trials in infants of its 21-valent pneumococcal conjugate vaccine candidate, 'GBP410' also known as SP0202, evaluating ...
NextCure, Inc. has announced that it has dosed its first patient in a Phase 1 clinical trial for LNCB74, an antibody-drug conjugate targeting B7-H4 for the treatment of multiple cancers. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback